NASDAQ: ONCS       Oncosec Medical
Last Price Today's Change   Day's Range   Trading Volume
2.18   -0.05 (2.24%)  2.11 - 2.43  85,944


Avg Volume (4 weeks):385,315
4 Weeks Range:1.51 - 2.66
4 Weeks Price Volatility (%):
52 Weeks Range:1.039 - 3.01
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3745  1934  355  2916 

Top 10 Active Counters
 CETX 2.57+1.623 
 VISL 0.377+0.083 
 AVP 5.60-0.05 
 DGLY 2.42+1.30 
 AESE 4.80+2.35 
 AABA 19.630.00 
 TGE 22.39+0.81 
 PFE 35.00-3.19 
 AKRX 0.09-0.094 
 NCLH 16.903+1.243 
Partners & Brokers